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Abstract
Background: Periostin, IFN-induced transmembrane protein 1 (IFITM1) and Wingless-type MMTV integration site family,
member 5B (Wnt-5b) were previously identified as the invasion promoted genes of head and neck squamous cell carcinoma
(HNSCC) by comparing the gene expression profiles between parent and a highly invasive clone. We have previously
reported that Periostin and IFITM1 promoted the invasion of HNSCC cells. Here we demonstrated that Wnt-5b
overexpression promoted the invasion of HNSCC cells. Moreover, stromelysin-2 (matrix metalloproteinase-10; MMP-10) was
identified as a common up-regulated gene among Periostin, IFITM1 and Wnt-5b overexpressing HNSCC cells by using
microarray data sets. In this study, we investigated the roles of MMP-10 in the invasion of HNSCC.
Methods and Findings: We examined the expression of MMP-10 in HNSCC cases by immunohistochemistry. High
expression of MMP-10 was frequently observed and was significantly correlated with the invasiveness and metastasis in
HNSCC cases. Next, we examined the roles of MMP-10 in the invasion of HNSCC cells in vitro. Ectopic overexpression of
MMP-10 promoted the invasion of HNSCC cells, and knockdown of MMP-10 suppressed the invasion of HNSCC cells.
Moreover, MMP-10 knockdown suppressed Periostin and Wnt-5b-promoted invasion. Interestingly, MMP-10 overexpression
induced the decreased p38 activity and MMP-10 knockdown induced the increased p38 activity. In addition, treatment with
a p38 inhibitor SB203580 in HNSCC cells inhibited the invasion.
Conclusions: These results suggest that MMP-10 plays an important role in the invasion and metastasis of HNSCC, and that
invasion driven by MMP-10 is partially associated with p38 MAPK inhibition. We suggest that MMP-10 can be used as a
marker for prediction of metastasis in HNSCC.
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Introduction
Head and neck squamous cell carcinoma (HNSCC) is one of the
most common types of human cancer, with an annual incidence of
more than 500,000 cases worldwide [1]. Despite the advances of
treatment strategies, the mortality rate and failure of treatment
options in HNSCC patients are still high. High mortality and poor
prognosis of HNSCC are predicted by occurrence of lymph node
metastasis, which is a common event in cancer patients [2].
HNSCC develops through the accumulation of multiple genetic
and epigenetic alterations in a multi-step process [3]. Attempts to
identify the genes involved in the metastasis are pivotal for the
early prediction of HNSCC behavior. The process of metastasis
consists of sequential and selective steps including proliferation,
induction of angiogenesis, detachment, motility, invasion into
circulation, aggregation and survival in the circulation, cell arrest
in distant capillary beds and extravasation into organ parenchyma
[4,5]. The identification of novel invasion and metastasis related
molecules in HNSCC and the better understanding of the
mechanisms by which carcinoma cells undergo during the steps
of invasion and metastasis are of fundamental importance to
design better therapeutic strategies for treating this disease.
Gene expression microarrays have been emerged and their
widespread use has led to the identification of potential candidate
genes. Further investigation of the biological behaviors and
significant clinical outcome of these genes particularly in HNSCC
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e25438is of great interest. We previously established a HNSCC cell line,
MSCC-1, from lymph node metastasis [6]. Moreover, we isolated
a highly invasive clone MSCC-Inv1 from MSCC-1 cells by using
an in vitro invasion assay device [7]. Then, we compared the
transcriptional profile of parent cells (MSCC-1) and a highly
invasive clone (MSCC-Inv1) by microarray analysis in order to
identify genes that differ in their expression [8]. Several genes were
selectively overexpressed in the highly invasive clone. Among these
genes, Periostin (osteoblast-specific factor 2 (fasciclin I like)) was
the most highly expressed gene and the second was IFITM1 (IFN-
induced transmembrane protein 1). In fact, we demonstrated that
Periostin and IFITM1 promoted invasion both in vitro and in vivo
[8,9]. We also identified Wingless-type MMTV integration site
family, member 5B (Wnt-5b) as the third highly expressed gene in
MSCC-Inv1. Here, we confirmed the capability of Wnt-5b to
promote the invasion of HNSCC cells in vitro. Moreover, we
identified matrix metalloproteinase-10 (MMP-10) as a common
upregulated gene by invasion promoting molecules including
Periostin, IFITM1 and Wnt-5b. Matrix metalloproteinases
(MMPs) represent a family of zinc-dependent proteinases which
are able to degrade ECM components such as collagens and
proteoglycans and they have a role in normal development and
tissue damage in various pathophysiological conditions involving
arthritis, wound healing and tumor development [10]. MMPs can
be classified into subgroups including; collagenases, stromelysins,
gelatinases, and membrane type MMPs [11]. Some members of
MMPs are implicated in the invasion and metastasis in HNSCC
such as MMP-2, membrane type-1 MMP (MT1-MMP), and
MMP-9 [12,13]. Overexpression of these MMPs has been
correlated with the invasion, metastasis, and poor prognosis. In
the present study, we investigated the roles of MMP-10 in the
invasion of HNSCC.
Results
Wnt-5b promotes the invasion of HNSCC
Wnt-5b is a member of the Wnt gene family, a group of secreted
glycoproteins that plays an important role in oncogenesis and in
several developmental processes and triggers intracellular respons-
es through various signaling pathways. By comparing the
transcriptional profile of the parent cells and the highly invasive
clone by microarray analysis, Wnt-5b was the third highly
expressed gene in the highly invasive clone after Periostin and
IFITM1. We first examined whether Wnt-5b was involved in the
invasion of HNSCC. The higher expression of Wnt-5b in the
highly invasive clone compared to the parent cells was verified by
RT-PCR (Figure 1A). We examined the expression of Wnt-5b
mRNA in six HNSCC cell lines. Wnt-5b mRNA expression was
noted in almost all of the HNSCC cell lines except HSC4 cell
(Figure 1A). To clarify the role of Wnt-5b in the invasiveness of
HNSCC, we generated the Wnt-5b-overexpressing cells by
transfection of Wnt-5b into HSC4 cells without Wnt-5b
expression. After getting the stable clone of Wnt-5b-overexpressing
cells (Figure 1B), they were used for checking the invasiveness by in
vitro invasion assay. Wnt-5b overexpression significantly enhanced
the invasion of HNSCC cells in vitro (Figure 1B). To confirm the
Wnt-5b-promoted invasion of HNSCC cells, we examined the
knockdown of Wnt-5b by using siRNA in HSC2 cells with high
expression of Wnt-5b. Treatment of Wnt-5b siRNA reduced the
expression of Wnt-5b mRNA and significantly inhibited the
invasion (Figure 1B). Although Wnt-5b did not affect cell growth
(Figure 1C), it significantly promoted cell motility of HNSCC cells
as demonstrated by wound healing assay (Figure 1D). Interesting-
ly, Wnt-5b siRNA significantly inhibited cell motility of HNSCC
cells (Figure 1D). Moreover, we compared the gene expression
profile between control and Wnt-5b-overexpressing HSC4 cells by
microarray analysis (Data S1). S100A8, SERPINB4, osteopontin
and SERPINB3 were upregulated and TGF-ß2, CDH11 and
thrombospondin 1 were downregulated in Wnt-5b-overexpressing
cells (Table S1).
MMP-10 is identified as a common target gene for
Periostin, IFITM1 and Wnt-5b overexpression
To identify the common target genes for Periostin, IFITM1 and
Wnt-5b overexpression, we compared the gene expression profiles
between control HSC2 cells and Periostin-overexpressing HSC2
cells, control Ca9-22 cells and IFITM1-overexpressing Ca9-22
cells, and control HSC4 cells and Wnt-5b-overexpressing HSC4
cells (Figure 2A). As a result, several groups of genes with variable
biological functions in normal development and in the process of
malignancy were found to be common in Periostin, IFITM1, and
Wnt-5b-overexpressing cells (Figure 2B). A number of common
target genes with variable biological behaviors including cell
adhesion, cell proliferation, apoptosis, cell cycle and others were
identified. Gene ontology analysis was done by using Gene Spring
GX software to identify the biological functions of these molecules
(Figure 2B). Common up-regulated genes between Periostin- and
IFITM1-overexpression, Periostin- and Wnt-5b-overexpression
and IFITM1- and Wnt-5b-overexpression are listed in Table S2,
S3 and S4, respectively. Several genes were the highly upregulated
among Periostin-, IFITM1-, and Wnt-5b-overexpressing HNSCC
cells (Table S5). Among them, stromelysin-2 (MMP-10) was
included. MMPs are known as a family of zinc-dependent
proteinases which are able to degrade ECM components and
they have a role in tumor development [10]. However, little is
known about involvement of MMP-10 in the invasion and
metastasis of cancer cells. Therefore, we focused on MMP-10 as
a common upregulated molecule induced by invasion related
factors of HNSCC and examined its role in the invasion of
HNSCC.
High expression of MMP-10 is well correlated with
invasion patterns and metastasis in HNSCC
We first examined the expression of MMP-10 in 30 normal
oral mucosal tissues and 116 HNSCC cases by immunohisto-
chemistry. Clinical information of 116 patients including age,
location, tumor size, invasion pattern, metastasis, tumor stage,
T N Mc l a s s i f i c a t i o n ,t r e a t m e n t ,s u r v i v a la n dM M P - 1 0e x p r e s -
sion is shown in Data S2. To demonstrate the antibody
specificity of immunohistochemical staining of MMP-10, we
performed immunohistochemical staining without secondary
antibody or without primary antibody as a negative control
(Figure S1). High expression of MMP-10 was observed in 89 of
116 (76.7%) HNSCC cases, whereas non-neoplastic epithelium
did not show MMP-10 expression (Figure 3A). Then, we
compared the MMP-10 expression with invasion pattern, stage
grouping and lymph node metastasis (Table 1). We used the
Jacobsson’s classification (Patterns I-IV) for evaluation of
invasion pattern (Figure S2) [14]. Out of 116 HNSCC cases,
9, 12, 62, and 33 cases showed the pattern I, II, III, and IV,
respectively (Table 1). Interestingly, the incidence of MMP-10
positive cases in the pattern III and IV was significantly higher
than that in the pattern I and II (Figure 3B). It is well known
that patterns III and IV are corresponding to poor differenti-
ation and high metastatic rate [14]. The correlation between
MMP-10 expression and invasion pattern was statistically
significant (P,0.001) (Table 1). We also compared MMP-10
MMP-10 Promotes Invasion of HNSCC
PLoS ONE | www.plosone.org 2 October 2011 | Volume 6 | Issue 10 | e25438Figure 1. Wnt-5b promotes the invasion of HNSCC. A, Expression of Wnt-5b in the highly invasive clone and HNSCC cell lines. Expression of
Wnt-5b mRNA in MSCC-1, MSCC-Inv1 as well as six HNSCC cell lines; HSC2, HSC3, HSC4, Ca-9-22, Ho-1-N-1, and Ho-1-U-1 was examined by RT-PCR.
Expression of Wnt-5a mRNA was also examined in 6 HNSCC cell lines. GAPDH was used as a loading control. B, Wnt-5b promoted the invasion of
HNSCC cells. For generation of Wnt-5b-overexpressing cells, Wnt-5b expression vector was transfected into HSC4 cells without Wnt-5b expression.
We obtained the stable clone and the expression of Wnt-5b was examined by Western blotting with anti-Wnt-5b polyclonal antibody (left upper
panel). We used empty vector transfected cells (empty) as a control. b-actin expression was used as a loading control. The invasiveness of Wnt-5b-
overexpressing cells (right upper panel) was examined by in vitro invasion assay. 1.5610
5 cells were placed on the upper compartment of the cell
culture insert. After 12h of incubation, the penetrated cells onto the lower side of the membrane were fixed in formalin and stained with hematoxylin.
HSC2 cells with Wnt-5b expression was transfected by Wnt-5b siRNA (siWnt-5b) or control siRNA (siControl). A scrambled sequence that does not
show significant homology to rat, mouse or human gene sequences was used as a control. The effect of knockdown was evaluated by RT-PCR (left
lower panel). GAPDH was used as a loading control. The invasiveness of Wnt-5b-knocked-down cells was examined by in vitro invasion assay (right
lower panel). After 24 h of incubation, the penetrated cells onto the lower side of the membrane were fixed in formalin and stained with hematoxylin.
The bars show the average values and SDs of three independent experiments. *Significantly different from empty vector transfected cells or control
siRNA transfected cells at P,0.01. C, Cell proliferation of Wnt-5b-overexpressing cells and Wnt-5b-knocked-down cells. Cells were plated on 24 well
plates, and trypsinized cells were counted by cell counter at 0, 2, 4 and 6 day. The bars show the average values and SDs of three independent
experiments. D, Migration of Wnt-5b-overexpressing cells and Wnt-5b-knocked-down cells. Migration of the cells was determined by wound healing
assay. At 24 h after scratching the cells, phase-contrast images (106 field) of the wound healing process were photographed digitally with an
inverted microscope. The distance of the wound areas were measured on the images, set at 100% for 0 h, and the mean percentage of the total
distances of the wound areas was calculated. The bars show the average values and SDs of three independent experiments. *Significantly different
from empty vector transfected cells or control siRNA transfected cells at P,0.01.
doi:10.1371/journal.pone.0025438.g001
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available for stage grouping (I-IV) according to the criteria of
the Japan Society for Head and Neck Cancer [15]. Most cases
(97.1 %) showed high expression of MMP-10 in advanced stage
group (III and IV), while 46.7 % of cases showed high
expression of MMP-10 in early stage group (I and II). The
correlation between MMP-10 expression and stage grouping
was statistically significant (P,0.001) (Table 1). In addition,
MMP-10 expression was significantly correlated with lymph
node metastasis (P,0.001) (Table 1 and Figure 3B). Twenty-
nine of 89 HNSCC cases with high expression of MMP-10 had
lymph node metastasis, while 5 of 27 HNSCC cases with low
expression of MMP-10 had lymph node metastasis (Figure 3B).
Moreover, we examined the correlation between MMP-10
expression and survival in HNSCC cases. Forty-two HNSCC
cases were available for survival analysis. Interestingly,
Figure 2. MMP-10 and MMP13 are common upregulated genes by Periostin, IFITM1, and Wnt-5b overexpression. A, Schema shows
the strategy to identify the common target of invasion related molecules. Periostin, IFITM1, and Wnt-5b are identified as the invasion related
molecules by comparing the gene expression profile between the parent (MSCC-1 cells) and a highly invasive clone (MSCC-Inv1 cells). To identify
common targets of invasion related molecules, we compared the gene expression profiles of control vs. Periostin-overexpressing HSC2 cells, control
vs. IFITM1-overexpressing Ca9-22 cells, and control vs. Wnt-5b-overexpressing HSC4 cells. Ectopic expression level of Periostin, IFITM1 and Wnt-5b in
each cells are shown by RT-PCR. GAPDH expression was used as a loading control. B, Several upregulated genes were found between Periostin and
IFITM1, Periostin and Wnt-5b, and Wnt-5b and IFITM1. By using Gene Ontology software, we identified the biological functions of these genes. The
table shows these common upregulated genes comprising diverse families with variable biological functions.
doi:10.1371/journal.pone.0025438.g002
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PLoS ONE | www.plosone.org 4 October 2011 | Volume 6 | Issue 10 | e25438Figure 3. High expression of MMP-10 is observed in HNSCC cases. A, Immunohistochemical expression of MMP-10 in 116 HNSCC cases and
30 normal epithelia. Normal epithelium is completely negative for MMP-10 compared to HNSCC cases in which most tumor cells showed highly
expression of MMP-10. Representative case of low MMP-10 expression in normal oral epithelium and HNSCC case (Jacobsson’s classification Pattern I),
and representative cases of high expression of MMP-10 (low and high magnification) in HNSCC cases (Jacobsson’s classification Pattern IV) are shown.
Scale bar is shown in each picture. B, Correlation between MMP-10 expression and invasion and metastasis in HNSCC cases. Left graph shows the
relationship between MMP-10 expression and pattern of invasion. The Jacobsson’s classification (Patterns I-IV) was used for evaluation of invasion
pattern (Figure S1) [14]. *Significantly different from pattern I or II at P,0.01. Right graph exhibits the relationship between MMP-10 expression and
metastasis. *Significantly different from low expression of MMP-10 at P,0.01. C, MMP-10 expression and poor outcome. Forty-two Italian HNSCC
cases were available for survival analysis. Kaplan-Meier curves show survival of HNSCC patients with high expression of MMP-10 (N
, N=34) or low
expression of MMP-10 (m, N=8).
doi:10.1371/journal.pone.0025438.g003
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with high expression of MMP-10 tended to show poor
prognosis (Figure 3C).
MMP-10 promotes invasion of HNSCC
We next examined MMP-10 mRNA and protein in 6 HNSCC
cell lines by RT-PCR and Western blot analysis, respectively.
High expression of MMP-10 mRNA and protein was observed in
Ca9-22, Ho-1-U-1 and Ho-1-N-1 cells (Figure 4A). In HSC2,
HSC3 and HSC4 cells, MMP-10 expression was low (Figure 4A).
MMP-10 protein expression corresponded to mRNA expression
level. To investigate whether MMP-10 promotes the invasion of
HNSCC in vitro, we generated MMP-10-overexpressing cells by
using HSC2 and HSC3 cells with low expression of MMP-10
(Figure 4B). We confirmed the higher activity of MMP-10 in
conditioned media of MMP-10-overexpressing cells by stromelysin
zymography (Figure 4B). Although MMP-10 overexpression did
not affect the cell proliferation (data not shown), it dramatically
enhanced the invasive activity in both HSC2 and HSC3 cells
(P,0.05) (Figure 4C). To further confirm the MMP-10-mediated
invasion of HNSCC cells, we examined the knockdown of MMP-
10 by using siRNA in Ca-9-22 and Ho-1-N-1 cells with high
expression of MMP-10. For MMP-10 knockdown, we used 3
different siRNAs (#1, #2 and #3). All siRNAs including cocktail
of 3 siRNAs reduced MMP-10 expression (Figure S3). We used
cocktail of 3 siRNAs in the following studies. MMP-10 knockdown
inhibited the expression of MMP-10 mRNA and protein in Ca9-
22 and Ho-1-N-1 cells (Figure 4D). MMP-10 knockdown
significantly suppressed the invasion of HNSCC cells (Figure 4E).
Taken all together, these findings indicate that MMP-10 plays an
important role in the invasion of HNSCC cells.
MMP10 knockdown suppresses the Periostin and Wnt-
5b-promoted invasion of HNSCC cells
Our present findings revealed that MMP-10 is a common
upregulated gene among Periostin, IFITM1, and Wnt-5b
overexpression. We compared the expression of MMP-10 in
Periostin, IFITM1, and Wnt-5b-overexpressing cells with that in
control cells. MMP-10 was found to be upregulated by Periostin or
Wnt-5b (Figure 5A), but not by IFITM1 (data not shown). In our
microarray analysis, 17.4 fold increase of MMP-10 expression was
observed in Periostin-overexpressing HSC2 cells and 5.8 fold
increase of MMP-10 expression was observed in Wnt-5b-
overexpressing HSC4 cells. Therefore, we examined the potential
role of MMP-10 in Periostin and Wnt-5b-promoted invasion in
HNSCC. We examined the effect of MMP-10 knockdown on the
invasion in Periostin-overexpressing Ca9-22 cells and in Wnt-5b-
overexpressing HSC4 cells. Expression of MMP-10 protein was
reduced by MMP-10 knockdown in Periostin- and Wnt-5b-
overexpressing cells (Figure 5B). Interestingly, MMP-10 knock-
down significantly suppressed the Periostin- and Wnt-5b-promot-
ed invasion (Figure 5C), indicating that MMP-10 may play a role
in the invasiveness driven by Periostin- and Wnt-5b-overexpres-
sion in HNSCC. We also examined MMP-10 knockdown in
Periostin-overxpressiong HSC2 cells (Figure S4). In similar to
Periostin-overxpressiong Ca9-22 cells, MMP-10 siRNA sup-
pressed the invasive capacities in Periostin-overxpressiong HSC2
cells. In addition, MMP-10 knockdown significantly inhibited the
invasion in control Ca9-22 cells, while MMP-10 knockdown
slightly inhibited the invasion in control HSC2 and HSC4 cells
(Figure 5C and Figure S4). In Ca9-22 cells, high level of MMP-10
expression was observed, but not in HSC2 and HSC4 cells
(Figure 4A). As Ca9-22 cells showed endogenous MMP-10
expression at higher levels, we thought that MMP-10 siRNA
suppressed invasive capacities through downregulation of endog-
enous MMP-10 expression in Ca9-22 cells. The level of
suppression by MMP-10 knockdown was most likely dependent
on the expression level of MMP-10.
MMP-10-promoted invasion is associated with p38
inhibition
In order to know the mechanism of MMP-10 promoted
invasion, we observed the activity of cell signaling molecules such
as p38, FAK, RSK, Akt, Src, and ERK by western blotting using
phosphorylation specific antibody in control and MMP-10
overexpressing cells. Among these molecules, p38 was inactivated
by MMP-10 overexpression (Figure 6A). To further confirm the
involvement of p38 inhibition in MMP-10-promoted invasion, the
invasive ability of control and MMP-10-overexpressing cells after
treatment with p38 inhibitor, SB203580 was examined. Interest-
ingly, SB203580 treatment significantly promoted the invasion of
control cells with p38 activity (Figure 6B). On the other hand,
SB203580 treatment did not promote the invasion in MMP-10
overexpressing cells without p38 activity. In addition, we
examined if a p38 inhibitor rescued the block of invasion induced
by MMP10 knockdown in MMP-10 overexpressing HSC2 and
HSC3 cells. MMP-10 knockdown in MMP-10-overexpressing cells
promoted the invasive capacity after treatment with p38 inhibitor
(Figure S5). However, p38 inhibitor did not fully rescue the
invasive capacity suppressed by MMP-10 siRNA (Figure S5).
Moreover, we confirmed that addition of conditioned media from
MMP-10-overexpressing cells inhibited p38 activity in HSC2 and
HSC3 cells (Figure 6C). We also examined the p38 activity and the
invasion by MMP-10 knockdown in MSCC-Inv1 cells. In MSCC-
Inv1 cells, MMP-10 knockdown slightly upregulated p38 activity
(Figure 6D) and inhibited the invasive activity (Figure 6E).
Discussion
Invasion and metastasis are the major problem and the greatest
obstacle for the treatment of HNSCC. Therefore, it is important to
Table 1. Correlation between MMP-10 expression and
clinico-pathologic findings in HNSCC.
MMP-10 expression
No. of cases Low High P value
Non-neoplastic
epithelium
30 28(93.3%) 2(6.7%) P,0.001
HNSCC 116 27(23.3%) 89(76.7%)
Pattern of invasion
Grade I 9 8(88.9%) 1(11.1%) P,0.001
Grade II 12 10(83.3%) 2(16.7%)
Grade III 62 8(12.9%) 54(87.1%)
Grade IV 33 1(3%) 32(97.0%)
Stage grouping
I & II 15 8(53.5%) 7(46.7%) P,0.001
III & IV 34 1(2.9%) 33(97.1%)
Metastasis
2 51 22(43.1%) 29(56.9%) P,0.001
+ 65 5(7.7%) 60(92.3%)
doi:10.1371/journal.pone.0025438.t001
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PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e25438Figure 4. MMP-10 enhances the invasion of HNSCC cells. A, Expression of MMP-10 mRNA and protein in six HNSCC cell lines. Expression of
MMP-10 mRNA in HSC2, HSC3, HSC4, Ca-9-22, Ho-1-N-1, and Ho-1-U-1 was examined by RT-PCR. GAPDH was used as a loading control. MMP-10
protein expression level was evaluated in the six HNSCC cell lines by Western blot analysis. Images of short and long exposure of MMP-10 protein
expression are shown. ß-actin was used as a loading control. B, Generation of MMP-10-overexpressing cells. We obtained several clones by
transfection with pBICEP-FLAG-tagged MMP-10 in HSC2 and HSC3 cells. Ectopic expression of MMP-10 was determined by Western blotting with anti-
FLAG antibody (left panel). b-actin was used as a loading control. Enzymatic activity of MMP-10 was detected by stromelysin zymography (right
panel). Active form of MMP-10 (arrow head) was detected in conditioned media of MMP-10-overexpressing cells. C, Invasive activity of MMP-10-
overexpressing HSC2 (left panel) and HSC3 (right panel) cells in comparison with empty vector transfected HSC2 and HSC3 cells (empty) by in vitro
invasion assay. Cells were fixed after incubation of 12 h or 20 h in HSC2 cells or HSC3 cells, respectively. The figure shows the stained lower side of
the membrane where the cells penetrated (upper panel). The graphs show the number of invaded cells in MMP-10-overexpressing and empty vector
transfected cells (lower panel). The bars show the average values and SDs of three independent experiments. *Significantly different from empty
vector transfected cells at P,0.01. D, MMP-10 siRNA suppressed the invasion of HNSCC cells. Cocktail of 3 different MMP-10 siRNAs was transiently
transfected into Ca-9-22 and Ho-1-N-1 cells with MMP-10 expression. A scrambled sequence that does not show significant homology to rat, mouse
or human gene sequences was used as a control. After 48 h of transfection, expression of MMP-10 mRNA and protein was examined by RT-PCR and
Western blotting (WB), respectively. GAPDH mRNA and b-actin protein were used as a loading control. Densitometric analysis of MMP-10 expression
was performed. MMP-10/GAPDH ratio is shown. E, Suppression of invasion by MMP-10 knockdown in Ca9-22 and Ho-1-N-1 cells. The invasiveness of
MMP-10 knocked-down cells was examined by in vitro invasion assay in comparison with control siRNA transfected cells. A scrambled sequence that
MMP-10 Promotes Invasion of HNSCC
PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e25438identify novel molecules involved in the invasion and metastasis of
HNSCC. We identified several invasion related genes by
comparing the gene expression profiles between parent cells and
a highly invasive clone [8]. Periostin and IFITM1 were identified
as the highest genes in a highly invasive clone and their
involvement in invasion were confirmed by in vitro and in vivo
does not show significant homology to rat, mouse or human gene sequences was used as a control. After 24 h incubation, cells were fixed and the
number of invaded cells was counted. The figure shows the stained lower side of the membrane where the cells penetrated (left panel). The graph
shows the number of invaded cells (right panel). The bars show the average values and SDs of three independent experiments. *Significantly different
from control siRNA transfected cells at P,0.01.
doi:10.1371/journal.pone.0025438.g004
Figure 5. MMP-10 knockdown inhibits Periostin and Wnt-5b-promoted invasion. A, The expression of MMP10 mRNA was examined by RT-
PCR in control Ca9-22 cells, Periostin-overexpressing Ca9-22 cells, control HSC4 cells and Wnt-5b-overexpressing HSC4 cells. GAPDH expression was
used as a loading control. B, MMP-10 knockdown into Periostin- and Wnt-5b-overexpressing cells. Cocktail of 3 different MMP-10 siRNAs was
transiently transfected into Periostin-overexpressing Ca-9-22 cells and Wnt-5b-overexpressing HSC4 cells. A scrambled sequence that does not show
significant homology to rat, mouse or human gene sequences was used as a control. After 48 h of transfection, MMP-10 protein level was examined
by Western blot analysis with anti-MMP-10 antibody in MMP-10 siRNA transfected Periostin-overexpressing cells. ß-actin was used as a loading
control. C, The invasiveness of MMP-10 siRNA transfected Periostin-overexpressing Ca-9-22 cells (left panel) and Wnt-5b-overexpressing HSC4 cells
(right panel) was examined by in vitro invasion assay. After 18 h incubation of HSC4 cells and 24 h incubation of Ca9-22 cells, cells were fixed and the
number of invaded cells was counted. The figure shows the stained lower side of the membrane where the cells penetrated (upper panel). Graphs
show the number of invaded cells in knockdown and control cells (lower panel). The bars show the average values and SDs of three independent
experiments. *Significantly different from control at P,0.01.
doi:10.1371/journal.pone.0025438.g005
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invasion of HNSCC cells (Figure 1). So far, there is only one report
that Wnt-5b is upregulated in cancer cell lines and little is known
about the role of Wnt-5b in cancer [16]. It has previously been
shown that Wnt-5a is involved in the invasion of various cancers
including melanoma, breast cancer, gastric cancer, pancreatic
Figure 6. p38 inhibition is involved in promoting invasion by MMP-10. A, p38 inhibition was noted in MMP-10 overexpressing cells. Levels
of total and phosphorylated forms of p38, FAK, RSK, Akt, Src, and ERK in control and MMP-10 overexpresing cells by western blotting. B, Invasion of
control and MMP-10 overexpressing cells after treatment by p38 inhibitor. The invasiveness of was examined by in vitro invasion assay in empty
vector transfected cells and MMP-10 overexpressing cells with SB203580 treatment. Empty vector transfected cells were used as a control. After 12 h
incubation, cells were fixed and the number of invaded cells was counted. The figure shows the stained lower side of the membrane where the cells
penetrated (upper panel). Graphs show the number of invaded cells (lower panel). The bars show the average values and SDs of three independent
experiments. *Significantly different from empty vector transfected cells without SB203580 treatment at P,0.01. C, p38 activity after treatment with
conditioned media from MMP-10 overexpressing cells. Conditioned media from MMP-10 overexpressing HSC2 and HSC3 cells was collected after
48 h of plating. After adding conditioned media for 0, 6, 12 and 24 h, HSC2 or HSC3 cells were collected. Expression of phospho-p38 and p38 was
examined by Western blot analysis. D, MMP-10 siRNA upregulates p38 activity in HNSCC cells. Cocktail of 3 different MMP-10 siRNAs was transiently
transfected into MSCC-Inv1 cells. A scrambled sequence that does not show significant homology to rat, mouse or human gene sequences was used
as a control. After 48 h of transfection, expression of MMP-10 protein was examined by Western blotting. Levels of total and phosphorylated forms of
p38 were also examined by Western blotting. b-actin expression was used as a loading control. E, Suppression of invasion by MMP-10 knockdown in
MSCC-Inv1 cells. The invasiveness was examined by in vitro invasion assay. After 6 h incubation, cells were fixed and the number of invaded cells was
counted. The figure shows the stained lower side of the membrane where the cells penetrated (upper panel). The graph shows the number of
invaded cells (lower panel). The bars show the average values and SDs of three independent experiments. *Significantly different from control at
P,0.01.
doi:10.1371/journal.pone.0025438.g006
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80% identical to human Wnt-5a protein, Wnt-5b may be involved
in the migration and invasion of HNSCC in a similar manner.
In this study, we tried to identify the common target genes
induced by Periostin, IFITM1 and Wnt-5b by using microarray
data sets. Several molecules were identified as common upregu-
lated genes by Periostin, IFITM1, and Wnt-5b overexpression
(Table S5). Among them, we focused on the roles of MMP-10 in
the invasion of HNSCC. MMPs belong to the metzincin
superfamily of Zn-dependent proteinases [11]. All MMPs share
the pro-domain and the catalytic domains, and act on broad
spectrum of ECM components [24]. They are classified into
secreted (soluble) and membrane-anchored MMPs and they are all
synthesized as pro-enzymes, which require activation either
extracellularly or intracellularly [25]. The soluble MMPs including
collagenase, stromelysins, gelatinases, matrilysin, and others show
broader accessibility to ECM and have a role in tissue remodeling
events [26]. It seems necessary to know the types of MMPs that
specifically facilitate invasion and metastasis in HNSCC. So far,
MMP-2, MT1-MMP and MMP-9 are implicated in the invasion
and metastasis of HNSCC [12,13]. However, little is known about
involvement of MMP-10 in the invasion and metastasis of
HNSCC. In this study, we demonstrated that MMP-10 has the
ability to promote the invasion of HNSCC cells in vitro (Figure 4).
Indeed, high expression of MMP-10 was frequently observed in
HNSCC cases and was well correlated with malignant behaviors
such as high invasiveness, advanced stage and metastasis (Figure 3).
Moreover, HNSCC cases with high expression of MMP-10 tended
to show poor prognosis (Figure 3C). Our findings are supported by
a recent paper showing that PKCi–Par6a–Rac1 signaling axis
promoted anchorage-independent growth and invasion of non
small cell lung carcinoma (NSCLC) cells through induction of
MMP-10 expression [27]. In fact, MMP-10 expression is elevated
in NSCLC tissues and NSCLC patients whose tumors express
high MMP-10 levels exhibited significantly worse survival than
those whose tumors express low MMP-10 [27,28].
MMP-10/stromelysin-2 constitutes a group with MMP-3/
stromelysin-1. Although MMP-10 and MMP-3 are similar in their
amino acid sequence and substrate specificity, differential patterns
of expression on normal and transformed cells are different
between MMP-3 and MMP-10 [29–32]. In our analysis, MMP-3
was not upregulated by Periostin, IFITM1, and Wnt-5b
overexpression (data not shown). MMP-10 degrades various
components of the extracellular matrix and is considered as
collagenase-related connective tissue-degrading metalloprotei-
nases. The ability of MMP-10 to promote neoplasia has been
inferred to its secretion by peritumoral cells in response to the
presence of signals provided by the tumor cells [33]. In our
analysis, HNSCC cells themselves secreted MMP-10 in condi-
tioned media and promoted their invasiveness. The degradation of
collagenase-related connective tissue may be involved in promot-
ing invasiveness of HNSCC cells. Van Themsche et al. also clearly
showed that lymphoma cells could secrete MMP-10, notably
following exposure to cytokines such as IL-4, IL-6, and IL-13 [34].
Interestingly, MMP-10 is also upregulated in tongue cancer by
comparing genome-wide transcriptomic profiles between 53
primary tongue cancer and 22 matching normal tissues [35].
Moreover, other group showed that MMP-10 is a potential oral
cancer marker [36].
In this study, we found upregulation of MMP-10 by Periostin or
Wnt-5b overexpression, but not by IFITM1 (Figure 5A). Interest-
ingly, MMP-10 knockdown inhibited the invasion promoted by
Periostin or Wnt-5b overexpression (Figure 5C and Figure S4).
These findings indicate that MMP-10 may play an important role
in Periostin- or Wnt-5b-mediated invasion. In Figure 1B, Wnt-5b
knockdown suppressed invasion in HSC2 cells in spite of low
expression of MMP-10. We found that knockdown of MMP-10 in
HSC2 cells suppressed the invasion (67% of number of invaded
cells in comparison with control) (Figure S4). Therefore, we
suggest that Wnt-5b knockdown-suppressed invasion in HSC2
may be due to in part by MMP10 knockdown. Unknown factors
may influence on the regulation of MMP-10. We still do not know
the mechanism of upregulation of MMP-10 by Wnt-5b overex-
pression. It has recently been reported that Periostin was
frequently overexpressed in various types of human cancers [37].
We already demonstrated that interaction between Periostin and
integrins has a role in promoting invasion of HNSCC by triggering
the intracellular signaling and activating certain genes that are
involved in invasion [8,38]. In a previous report, Periostin and
MMP-10 were selectively upregulated in human osteoblasts in
comparison with human fibroblasts by microarray analysis [39].
As integrins can regulate the expression and activation of MMPs
and can guide them to their targets by simultaneous binding of
MMPs and ECM molecules [40], the interaction between integrin
and Periostin may induce MMP-10 expression. In addition, some
MMPs including MMP-1, MMP-2 and MMP-13 are involved in
Wnt-5a mediated invasion of cancer cells [19,21,41,42]. As human
Wnt-5b protein is 80% identical to human Wnt-5a protein, MMP-
10 may play an important role in Wnt-5b-mediated invasion of
HNSCC cells. As both Periostin and Wnt-5b are secreted protein,
MMP-10 may be transcriptionally upregulated by Periostin- or
Wnt-5b-mediated intracellular signaling. It has recently been
reported that MMP-10 is induced by TGF-ß mediated by
activation of MEF2A and downregulation of class IIa HDACs
[43]. We checked the microarray data of control vs Periostin-
overexpressing cells and control vs Wnt-5b-overexpressing cells.
Interestingly, MEF2A was upregulated 2.5-fold by Wnt-5b
overexpression (Data S1), suggesting that upregulation of MEF2A
by Wnt-5b overexpression may promote transcriptional activation
of MMP-10. In Periostin overexpression cells, upregulation of
MEF2A was not observed (data not shown). Thus, MMP-10 may
be transcriptionally upregulated through intracellular signaling.
To clarify the detailed mechanism of MMP-10 regulation by
Periostin or Wnt-5b in HNSCC cells, further experiments are
required.
In this study, we found that p38 MAPK activity was inhibited
by MMP-10 overexpression, and that the inhibition of p38 MAPK
was associated with MMP-10-promoted invasion. Moreover, we
examined if a p38 inhibitor rescued the block of invasion induced
by MMP10 knockdown in MMP-10 overexpressing HSC2 and
HSC3 cells. p38 inhibitor treatment slightly increased the invasion
in MMP-10 overexpressing HSC2 and HSC3 cells (Figure S5).
However, the invasive activity was not fully recued by suppression
of p38 activity. In addition, we found p38 activity was upregulated
by MMP-10 knockdown in MSCC-Inv1 cells. These results
indicate that suppression of p38 activity may be partially involved
in the invasion of HNSCC. This speculation is supported by the
previous findings that i) the inhibition of cancer cell invasion was
mediated by the activation of p38 MAPK pathway [44], and ii)
p38 activation was shown to suppress the metastatic colonization
in ovarian cancer [45]. However, the mechanism of promoting
invasion by suppression of p38 activity is still unclear. As shown in
Figure 6C, addition of conditioned media from MMP-10
overexpressing cells suppressed p38 activity, indicating that p38
activity is inhibited by secreted MMP-10 through intracellular
signaling. We also examined the p38 activity in Periostin or Wnt-
5b overexpressing cells (Figure S6). Wnt-5b overexpressing
suppressed p38 activity, but Periostin overexpression did not.
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Periostin may be required for another factor.
In summary, we have demonstrated that MMP-10 promotes
invasion in HNSCC and that MMP-10 mediates the Periostin-
and Wnt-5b-induced invasion. Indeed, the inhibition of p38
MAPK was partially involved in MMP-10 driven invasion in
HNSCC cells. These findings provide new insights into the roles of
MMP-10 in promoting invasion in HNSCC and indicate that
MMP-10 can be a valuable marker for predicting the invasion and
metastasis in HNSCC patients.
Materials and Methods
Cell lines and culture conditions
HNSCC cell lines (HCS2, HSC3, HSC4, Ca-9-22, Ho-1-N-1,
and Ho-1-U-1) were provided by the Japanese Collection of
Research Bioresources Cell Bank. These cells were maintained in
RPMI 1640 (Nacalai Tesque, Inc., Kyoto, Japan) supplemented
with 10% heat-inactivated fetal bovine serum (Gibco) and
100 units/ml penicillin-streptomycin (Gibco) under the condition
of 5% CO2 in air at 37uC. For proliferation assay, 5000 cells were
plated on 24-well plate and the cells were allowed to grow and
expand. The cells were then trypsinized and counted at 0, 2, 4,
and 6 days by using cell counter (Coulter Z1, Beckman-Coulter).
RT-PCR
Using RNeasy mini kit (Qiagen), total RNA from cultures of
confluent cells was isolated. These isolates were quantified and
their purity was evaluated by spectrophotometer. The cDNA
was synthesized from 1 mg of total RNA according to ReverTra
Dash (Toyobo Biochemicals, Tokyo, Japan). We used the
following primers; human Wnt-5b, 59-cgggagcgagagaagaact-39
(forward) and 59-tacacctgacgaagcagcac-39 (reveres: product size
505 bp), human Wnt-5a, 59-ggctggaagtgcaatgtctt-39 (forward)
and 59-ccgatgtactgcatgtggtc-39 (reveres: product size 234 bp),
human MMP-10, 59-ggctctttcactcagccaac-39 (forward) and 59-
tcccgaaggaacagattttg-39 (reveres: product size 176 bp) and
human glyceraldahyde-3-phosphate dehydrogenase (GAPDH)
59-tccaccaccctgttgctgta-39 (forward) and 59-accacagtccatgccat-
cac-39 (reverse: product size: 450 bp). Aliquots of total cDNA
were amplified with 1.25 units of rTaq-DNA polymerase
(Qiagen) and this amplification was done in a thermal cycler
( M y C y l e r ,B i o - R a d ,R i c h m o n d ,C A )for 30 cycles after initial 30
seconds of denaturation at 94uC, annealing for 30 seconds at
60uC, and extension for 1 minute at 72uCi na l lp r i m e r su s e d .
The amplification reaction products were resolved on 1.2 %
agarose/TAE gels (Nacalai Tesque, Kyoto, Japan), electropho-
resed at 100 mV, and then finally visualized by using ethidium
bromide.
Western blot analysis
Western blotting was carried out as previously described [8].
The protein concentrations were measured by Bradford protein
assay (Bio-Rad). Twenty mg of protein was subjected to 10 %
polyacrylamide gel electrophoresis, followed by electroblotting
onto a nitrocellulose filter. For detection of the immunocomplex,
the ECL western blotting detection system (Amersham) was used.
Anti-MMP-10 monoclonal antibody (Novocastra), anti-FLAG
monoclonal antibody (Sigma) and anti-ß-actin monoclonal
antibody (Sigma), phospho-p38 (Thr180/Tyr182) monoclonal
antibody (Cell Signaling Technology), phospho-FAK (Tyr576/
Tyr577) monoclonal antibody (Cell Signaling Technology),
phospho-RSK (Ser380) polyclonal antibody (Cell Signaling
Technology), phospho-Akt (Ser473) monoclonal antibody (Cell
Signaling Technology), phospho-Src (Tyr416) polyclonal antibody
(Cell Signaling Technology), phospho-ERK monoclonal antibody
(Santa Cruz Biotechnology. Inc), anti-p38 polyclonal antibody
(Cell Signaling Technology), anti-FAK polyclonal antibody (Cell
Signaling Technology), anti-RSK polyclonal antibody (Cell
Signaling Technology), anti-Akt polyclonal antibody (Cell Signal-
ing Technology), anti-Src polyclonal antibody (Cell Signaling
Technology), and anti-ERK monoclonal antibody (Cell Signaling
Technology) were used. Anti-Wnt-5b antibody was generated in
rabbits by immunization with synthetic peptides corresponding to
residue 254–269. For detection of phosphorylated proteins,
membranes were blocked with 3% milk/TBS-T and incubated
with phospho-specific antibodies overnight at 4uC. After washing
in TBS-T, membranes were incubated with specific secondary
antibodies, and the proteins were visualized as described earlier.
Generation of Wnt-5b-overexpressing HNSCC cells
The Wnt-5b plasmid (pPGK2-Wnt-5b) or the empty vector was
introduced into HSC4 cells, and the stable clones were obtained
by G418 selection (500 mg/ml, Gibco) in the culture medium. We
obtained pool and 4 stable clones. Cell transfection was performed
using FuGENE 6 HD (Roche) according to the manufacturer’s
instruction.
Silencing by siRNA
Wnt-5b siRNA (Wako, Osaka, Japan) is a 21-bp duplex
oligoribonucleotides corresponding to the nucleotides of the
human Wnt-5b mRNA sequences. The sense sequence is
gaacuuugccaaaggaucaTT. Three MMP-10 siRNAs (Oligo ID,
1135A-C, B-Bridge International, Inc.) are 21-bp duplexes
oligoribonucleotides corresponding to the nucleotides of the
human MMP-10 mRNA sequences. The sense sequences are:
#1; gaaguuaacagcagggacaTT, #2; gaguugagccuaagguugaTT,
and #3; gugcaauaggugagagaauTT. Logarithmically growing
cells were seeded at a density of 10
5 cells per 6-cm dish and
transfected with 5 nM Wnt-5b siRNA or 5 nM cocktail of 3
MMP-10 siRNAs using Oligofectamine (Invitrogen) according
to manufacturer’s instructions. Forty-eight hours after transfec-
tion, cells were used for in vitro invasion assay as described
below. A scrambled sequence that does not show significant
homology to rat, mouse or human gene sequences was used as a
negative control. The efficiency of siRNA was checked by RT-
PCR.
In vitro invasion assay
This experiment was done as previously described [8]. Briefly, a
24-well cell culture insert with 8 mm pores (3097, Falcon, Becton
Dickinson) was used. The membrane was coated by 20 mgo f
matrigel (Becton Dickinson), which is reconstituted basement
membrane substance. The lower compartment contained 0.5 ml
of serum-free medium. After trypsinization, 1.5610
5 cells were
resuspended in 100 ml of serum-free medium and placed in the
upper compartment of the cell culture insert for 6–24 hours. In an
additional assay, p38 inhibitor (SB203580; sigma) was added to
control and MMP-10 overexpressing cells after trypsinization and
before plating the cells on the upper compartment of the insert.
After incubation at 37uC, we fixed the cells that penetrate the
membrane into the lower side with formalin and these cells were
then stained by hematoxylin. The invasiveness of the cells was
determined by counting the penetrating cells onto the lower side of
the filter through the pores under a microscope at x100
magnification. We assayed 3 times and randomly selected 3 fields
were counted for each assay.
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For the wounding healing experiment, cells were seeded on 6
well plates and cells were allowed to grow to complete confluence.
Subsequently, a plastic pipette tip was used to scratch the cell
monolayer to create a cleared area, and the wounded cell layer
was washed with fresh medium to remove loose cells. Immediately
following scratch wounding (0 h) and after incubation of cells at
37uC for 24 h, phase-contrast images (106 field) of the wound
healing process were photographed digitally with an inverted
microscope. The distance of the wound areas were measured on
the images, set at 100% for 0 h, and the mean percentage of the
total distances of the wound areas was calculated.
Gene array analysis
The human focus array using the system containing 50000
genes probes was used for comparing the transcriptional profiles
between Wnt-5b overexpressing HSC4 cells and control HSC4
cells. This array contains a broad range of genes derived from
publicly available, well-annotated mRNA sequences. Total RNA
was isolated from cultures of confluent cells using the RNeasy Mini
Kit (Qiagen) according to the manufacturer’s instructions.
Preparations were quantified and their purity was determined by
standard spectrophometric methods. Data were expressed as the
average differences between the perfect match and mismatch
probes for the HSC4 gene (Data S1).
Tissue samples
Tissue samples of HNSCC were retrieved from the Surgical
Pathology Registry of University of Palermo (Italy), University of
Peradeniya and OMF unit, Kandy hospital (Sri Lanka), after
approval by the Ethical Committee of each institution. Informed
consent obtained from all patients was verbal for this study, and
then signature was obtained from all patients. For immunohisto-
chemical examination of MMP-10, 49 tissue samples of HNSCC
were selected from the Surgical Pathology Registry of University of
Palermo (Italy), and 67 tissue samples of HNSCC were selected
from the pathological files of University of Peradeniya and OMF
unit, Kandy hospital (Sri Lanka). Forty-nine Italian HNSCC cases
(32 male and 17 female; average age is 63.3612.6) were surgically
resected from 1998 to 2003 before radiochemotherapy. Sixty-
seven Sri Lankan HNSCC cases (42 male, 9 female and 16
unknown; average age is 50.2613.2) were surgically resected from
1998 to 2004 before radiochemotherapy. Collectively, 116
HNSCC cases were used for evaluation of MMP-10 expression
by immunohistochemical staining. Clinical information including
age, location, tumor size, invasion pattern, metastasis, tumor stage,
TNM classification, treatment and survival was gathered from
surgical records of the patients (Data S2). Among 116 HNSCC
cases, 63 cases showed metastasis to lymph node, and 2 cases
showed metastasis to lymph node and other organs. Moreover, 42
Italian HNSCC cases were available for survival analysis. Survival
time was calculated as the time interval between diagnosis and
date of last information. For deceased cases, the date of last
information was the date of death. For cases not known to be
deceased, the date of last information was the date that the case
was last known to be alive. All deceased cases died from HNSCC.
Tissues were fixed in 10% buffered formalin and embedded in
paraffin.
Immunohistochemistry
Tumor tissues were fixed in 10% formalin, embedded in
paraffin and cut into 4 mm thick. All HNSCC cases were
classified according to invasion pattern into 4 grades; pattern I,
pattern II, pattern III, and pattern IV [14]. For immunohisto-
chemical staining, tissue sections were deparafinized in xylene,
rehydrated in descending grades of ethanol. Endogenous
peroxidase activity was blocked with methanol containing 0.3%
H2O2 for 30 minutes. Antigen retrieval was done by microwaving
using citrate phosphate buffer (pH 6.0), then the sections were
incubated with the primary antibodies at 4uCo v e r n i g h t .
Immunohistochemical staining was carried out by a monoclonal
anti-MMP-10 antibody (Novocastra, 1:300). For detection of the
reaction after incubation with secondary antibodies, we used
diaminobenzidine (DAKO). The sections were counterstained by
haematoxylen, dehydrated in ascending grades of ethanol and
finally the slides were mounted. MMP-10 expression was defined
as high (over 10 % of the tumor cells showed strong or diffuse
staining) and low (less than 10 % of the cells showed weak or no
staining) by considering the percentage of positive cells and
overall staining intensity.
Generation of MMP-10-overexpressing cells
We cloned human MMP-10 into pBICEP2 (Sigma) using
cDNA of Ho-1-N-1 cells. We transfected MMP-10 into HSC2 and
HSC3 cells. Then, G418 (300 mg/ml, Gibco) was added to the
culture medium after 48 h of transfection. After 2 weeks of G418
selection, we obtained the stable pool clones. Cell transfections
were performed using FuGENE 6HD (Roche) according to the
manufacture’s instruction.
Stromelysin zymography
To detect the activity of MMP-10, we used Mini Zymo
Electrophoresis Kit (Life Laboratory Company, Yamagata, Japan),
according to the manufacturer’s instructions with some modifica-
tions. Briefly, cells were cultured for 48 h after plating. Then,
conditioned media were collected and were concentrated using
Amicon Ultra Centrifugal filter devices (Millipore). The condi-
tioned media were mixed with SDS sample buffer provided with
the kit and the mixtures were incubated for 15 min at room
temperature. The samples were then subjected to gel electropho-
resis. After washing, the gel was incubated for 40 h at 37uC in the
enzymatic reaction buffer. Then, the gel was stained in Coomasie
brilliant blue and destained in methanol/acetic acid solution with
gentle agitation on a shaking plate. The activity of MMP-10 was
identified by detection of clear bands in a background with a
uniform staining.
Statistical analysis
A P value ,0.05 was required for assessing the significance.
Correlation between variables was estimated using Fisher’s exact
test. Survival estimates were calculated by the Cox proportional
hazards method with one-month intervals. Statistical significance
based on Cox proportional hazards was determined using 95%
confidence intervals. The appropriateness of the Cox proportional
hazards model was assessed graphically.
Supporting Information
Data S1 Data of microarray analysis for comparing the gene
expression profiles between empty vector transfected HSC4 cells
and Wnt-5b transfected HSC4 cells.
(XLS)
Data S2 Summary of immunohistochemical staining including
information of HNSCC patients, clinico-pathological findings and
MMP-10 expression.
(XLS)
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staining of MMP-10. To demonstrate the antibody specificity of
immunohistochemical staining of MMP-10, we performed immu-
nohistochemical staining without secondary antibody as a negative
control. We also performed immunohistochemical staining
without primary antibody as a negative control. Two representa-
tive case of immuno-expression. Scale bar is shown in each
picture.
(TIFF)
Figure S2 Diagrammatic illustration of invasion pat-
tern (Jacobson et al. [14]). Pattern I: solid sheets with pushing
border, Pattern II: comparatively large tumor islands, Pattern III:
thin strands of tumor cells as well as small tumor islands, and
Pattern IV: scattered individual tumor cells.
(TIFF)
Figure S3 The efficiency of MMP-10 siRNA. Four different
MMP-10 siRNAs (#1, #2, #3 and cocktail) were transiently
transfected into Ca9-22 cells. A scrambled sequence that does not
show significant homology to rat, mouse or human gene sequences
was used as a control. After 48 h from transfection, MMP-10
mRNA was examined by RT-PCR. GAPDH was used as a
loading control.
(TIFF)
Figure S4 MMP-10 knockdown into Periostin-overex-
pressing cells. Cocktail of 3 different MMP-10 siRNAs was
transiently transfected into Periostin-overexpressing HSC2 cells. A
scrambled sequence that does not show significant homology to
rat, mouse or human gene sequences was used as a control. After
48 h of transfection, the invasiveness of MMP-10 siRNA
transfected Periostin-overexpressing HSC2 cells was examined
by in vitro invasion assay. After 14 h incubation of HSC2, cells
were fixed and the number of invaded cells was counted. Graphs
show the number of invaded cells in knockdown and control cells.
The bars show the average values and SDs of three independent
experiments. *Significantly different from control at P,0.01.
(TIFF)
Figure S5 SB203580 treatment in MMP-10 siRNA treat-
ed MMP-10-overexpressing cells. MMP-10 siRNA was
transfected into MMP-10-overexpressing HSC2 cells and MMP-
10-overexpressing HSC3 cells. Cocktail of 3 different MMP-10
siRNAs was transiently transfected into MMP-10-overexpressing
cells. A scrambled sequence that does not show significant
homology to rat, mouse or human gene sequences was used as a
control. After 48 h of transfection, cells were used for in vitro
invasion assay with or without p38 inhibitor, SB203580. After
12 h incubation, cells were fixed and the number of invaded cells
was counted. The figure shows the stained lower side of the
membrane where the cells penetrated (upper panel). The graph
shows the number of invaded cells (lower panel). The bars show
the average values and SDs of three independent experiments.
Scale bar is shown.
(TIFF)
Figure S6 p38 activity in Periostin-overexpressing Ca9-
22 and HSC4 cells and Wnt-5b-overexpressing HSC4
cells. Expression of phospho-p38 and p38 was examined by
Western blot analysis. ß-actin expression was used as a loading
control.
(TIFF)
Table S1 Upregulated and downregulated genes in Wnt-5b-
overexpressing cells.
(TIFF)
Table S2 Common up-regulated gene by Periostin and IFITM1
overexpression in HNSCC cells.
(TIFF)
Table S3 Common up-regulated gene by Periostin and Wnt5B
overexpression in HNSCC cells.
(TIFF)
Table S4 Common up-regulated gene by IFITM1 and Wnt5B
overexpression in HNSCC cells.
(PDF)
Table S5 Common up-regulated gene by Periostin, IFITM1
and Wnt-5b overexpression.
(TIFF)
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